Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum [NA]
This clinical trial update reports a completed study comparing two low molecular weight heparins as postpartum thromboprophylaxis.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study [Phase 4]
A Phase 4 pilot study comparing bleeding risk between rivaroxaban and apixaban in venous thromboembolism has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism [Phase 4]
A Phase 4 study compares bleeding risk between rivaroxaban and apixaban for treatment of acute venous thromboembolism.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty [Phase 2]
A Phase 2 trial evaluating SHR2285 tablets for prevention of venous thrombosis after total knee arthroplasty has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous Thromboembolism
A completed clinical trial assessing the reproducibility of plasma nucleosomes and free DNA as biomarkers for venous thromboembolism.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer
A completed clinical trial comparing the total health care costs of apixaban versus low molecular weight heparin in patients with venous thr…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism [Phase 4]
Phase 4 trial evaluating extended-duration low-dose apixaban to prevent recurrent venous thromboembolism in high-risk patients with provoked…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Neuromuscular Stimulation Versus Intermittent Compression for Venous Thromboembolism Prophylaxis in Critical Care [NA]
Clinical trial update indicates the completed study comparing neuromuscular stimulation versus intermittent compression for venous thromboem…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Incidence of Venous Thromboembolism in Patients With Pelvic and Acetabular Fractures (PAF)
A completed clinical trial update assessing the incidence of venous thromboembolism in patients with pelvic and acetabular fractures, includ…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Computed Tomography CT Venography During Postpartum Venous Thromboembolism [NA]
A completed clinical trial from Paris evaluating CT venography in postpartum venous thromboembolism (pulmonary embolism).
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)
This clinical trial update describes the PREDICTORS study investigating predictors of recurrent venous thromboembolism in patients with a hi…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot
A pediatric clinical trial evaluating safety and effectiveness of Pradaxa pellets (dabigatran etexilate) for venous thromboembolism in child…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT [Phase 4]
Phase 4 clinical trial evaluating individualized targeted prophylaxis for venous thromboembolism in patients undergoing total hip or total k…
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs [Phase 3]
Phase 3 trial evaluating apixaban for prevention of venous thromboembolism in patients with multiple myeloma treated with IMiDs has complete…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event [Phase 4]
Phase 4 clinical trial evaluating the role of statin therapy in venous dysfunction among patients with venous thromboembolism has completed.…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
A completed clinical trial update from NHLBI evaluating biomarkers related to venous thrombosis in people with sickle cell disease and sickl…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants [Phase 2]
A Phase 2 trial assessed REGN9933 for preventing venous thromboembolism after knee replacement surgery; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT [Phase 1, Phase 2]
A randomized trial comparing apixaban to enoxaparin for venous thromboembolism prevention after microsurgical breast reconstruction has comp…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer [Phase 3]
Phase 3 trial results for apixaban in the treatment of venous thromboembolism in cancer patients have been posted after study completion.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
Results from a UK matched-cohort study examine the risk of venous thromboembolism among people with systemic inflammatory disorders. The tri…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism [Phase 2]
Phase 2 clinical trial evaluating antithrombin to improve thromboprophylaxis and reduce trauma-related venous thromboembolism; currently enr…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)
CovCardioVasc-Study, a trial investigating cardiovascular complications in COVID-19, has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Low Molecular Weight hEparin vs. Aspirin Post-partum [NA]
A completed clinical trial comparing low molecular weight heparin with aspirin for postpartum prevention of venous thromboembolism.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer [Phase 3]
A Phase 3 trial comparing long-term Innohep (tinzaparin) to Warfarin for treating venous thromboembolism in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: AQT90 FLEX D-dimer Clinical Sensitivity and Specificity
Trial update reporting on the sensitivity and specificity of the AQT90 FLEX D-dimer assay for diagnosing venous thromboembolism.